Inc.;Syndax Pharmaceuticals;Syndax Pharmaceuticals, Inc.;Merck Patent GmbH;Pfizer Inc.
发明人:
Ordentlich, Peter,Meyers, Michel
申请号：
AU2016382780
公开号：
AU2016382780A1
申请日:
2016.12.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Described herein are methods for the treatment of heavily pre-treated recurrent ovarian cancer. In particular, methods are provided for the treatment of heavily pre-treated recurrent ovarian cancer with a combination of entinostat and an anti-PD-L1 antibody.
